Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

The Yorkshire RTC adopted regional purchase of all blood products.

  • Read more about The Yorkshire RTC adopted regional purchase of all blood products.

The Yorkshire RTC did not purchase, store or distribute commercial Factor 8 prior to 1981, but discussions were had with the Regional Health Authority around July 1981 regarding future policy in this matter.

  • Read more about The Yorkshire RTC did not purchase, store or distribute commercial Factor 8 prior to 1981, but discussions were had with the Regional Health Authority around July 1981 regarding future policy in this matter.

Dr Jack Darnborough (Director, East Anglian Blood Transfusion Centre) met with a representative from Cutter Laboratories to discuss the supply of Koate.

  • Read more about Dr Jack Darnborough (Director, East Anglian Blood Transfusion Centre) met with a representative from Cutter Laboratories to discuss the supply of Koate.

Barry Barber, sales manager at Cutter Laboratories, informed Dr Jack Darnborough (Cambridge RTC), about a request to tender for the next Factor 8 contract.

  • Read more about Barry Barber, sales manager at Cutter Laboratories, informed Dr Jack Darnborough (Cambridge RTC), about a request to tender for the next Factor 8 contract.

Dr William Maycock convinced Dr Jack Darnborough of the advantages of distributing commercial Factor 8.

  • Read more about Dr William Maycock convinced Dr Jack Darnborough of the advantages of distributing commercial Factor 8.

Dr Jack Darnborough agreed to organise the purchase and distribution of commercial Factor 8. He noted one of the reasons for his change of mind as being his knowledge that a haematologist in his region had been purchasing large quantities of commercial Factor 8, costing between £8,000 and £10,000 a year.

  • Read more about Dr Jack Darnborough agreed to organise the purchase and distribution of commercial Factor 8. He noted one of the reasons for his change of mind as being his knowledge that a haematologist in his region had been purchasing large quantities of commercial Factor 8, costing between £8,000 and £10,000 a year.

In his letter to Dr William Maycock, Dr Jack Darnborough rejected the idea of distributing Factor 8 on a supra-regional basis and of RTCs distributing commercial Factor 8 as well as NHS Factor 8 and cryoprecipitate.

  • Read more about In his letter to Dr William Maycock, Dr Jack Darnborough rejected the idea of distributing Factor 8 on a supra-regional basis and of RTCs distributing commercial Factor 8 as well as NHS Factor 8 and cryoprecipitate.

The North East Thames RTC (Brentwood) ceased to act as a wholesaler for BPL products.

  • Read more about The North East Thames RTC (Brentwood) ceased to act as a wholesaler for BPL products.

In a letter Dr Jean Harrison explained the situation with regard to charges for Factor 8. The situation prior to 1 April 1989 was that haemophilia centres were charged for any supply of Factor 8 by BPL above their free allocation.

  • Read more about In a letter Dr Jean Harrison explained the situation with regard to charges for Factor 8. The situation prior to 1 April 1989 was that haemophilia centres were charged for any supply of Factor 8 by BPL above their free allocation.

The North London RTC used Dr Simon Ardeman, a consultant haematologist at Edgware General Hospital, to act as the arbitrator between the various hospitals which received their Factor 8 from the North London RTC, to determine their allocation of Factor 8.

  • Read more about The North London RTC used Dr Simon Ardeman, a consultant haematologist at Edgware General Hospital, to act as the arbitrator between the various hospitals which received their Factor 8 from the North London RTC, to determine their allocation of Factor 8.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 671
  • Page 672
  • Page 673
  • Page 674
  • Current page 675
  • Page 676
  • Page 677
  • Page 678
  • Page 679
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.